Skip to content

Surgical Telemedicine in the COVID-19 Pandemic Era

Surgical Telemedicine in the COVID-19 Pandemic Era

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04376710
Enrollment
180
Registered
2020-05-06
Start date
2020-07-01
Completion date
2020-10-01
Last updated
2020-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID, Surgery

Keywords

Telemedicine, COVID, Surgery

Brief summary

The current COVID-19 pandemic has caused delays in initial or follow-up encounters between surgical patients and physicians. While this delay allows for resource allocation to those most severely affected by the pandemic, surgeons are faced with potential important delays in diagnosis and the expanding backlog of elective cases and initial evaluations. This project will assess surgeon and patient telemedicine perspectives. Pre-pandemic views on telemedicine among a cohort of surgeons will be obtained and compared to views at 3 months from the peak of the pandemic. Patients will be surveyed following telemedicine appointments with an anonymous questionnaire to learn about patient receptiveness to telemedicine. Barriers to implementation will be addressed throughout the duration of the study.

Interventions

OTHERCompletion of pre-pandemic survey

Surgeons will take a pre-pandemic survey to determine surgeon perceptions to telemedicine and barriers to implementation.

OTHERCompletion of survey after peak of pandemic

Surgeons will take another survey after the peak of pandemic to determine surgeon perceptions to telemedicine and barriers to implementation.

OTHERCompletion of post telemedicine encounter survey

Patients will take a post telemedicine encounter survey to determine patient perceptions to telemedicine and barriers to implementation.

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
31 Days to 18 Years
Healthy volunteers
Yes

Inclusion criteria

1. Surgical faculty at participating institutions will receive surveys regarding telemedicine early in the start of the study to assess baseline perceptions. These same group of surgeons will receive subsequent surveys 3 months after the peak of the pandemic to evaluate telemedicine perceptions following a rapid implementation and adoption of telemedicine. 2. Surgical patients evaluated from the start of the study through a 6-month period will be included in the study. They will have the option after each telemedicine encounter to complete an anonymous survey regarding perceptions to this technology.

Exclusion criteria

1. No exclusions for surgical faculty are identified. Accrual of data from this group will be limited only by response rates to administered surveys. 2. Exclusions for surgical patients will include the inability to access the technology required for a telemedicine consultation (e.g.: absence of a camera enabled smartphone, absence of a required internet or cellular connection to perform a telemedicine encounter). The investigators will keep a list of reasons for the inability to perform a telemedicine encounter to identify the barriers to implementation among patients.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate surgeon perceptions to telemedicine and perceived barriers to implementation6 monthsSurgeons will take an anonymous survey early after the start of the study regarding perceptions to telemedicine and perceived barriers to implementation. Surgeons will be asked again after 3 months from the peak of the pandemic to take another survey to assess how the pandemic has changed perceptions to telemedicine and the observed barriers to implementation.
Evaluate patient perceptions to telemedicine and perceived barriers to implementation6 monthsPatients will take an optional anonymous survey at the end of each telemedicine encounter to assess patient perceptions to telemedicine and barriers to implementation.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026